Research on Sleep and Emotion Testing of Tea Theanine Casein Hydrolysate Pressed Candy

NCT ID: NCT07207252

Last Updated: 2025-10-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

171 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-28

Study Completion Date

2024-12-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study evaluates the improvement of sleep, emotion, and skin by standardizing the use of the blend (Tea Theanine Casein Hydrolysate Pressed Candy, whose active ingredients include Tea Theanine, Casein Hydrolysate, and Saffron Extract).

This is a randomized, double-blind trial for Chinese people aged 20-55. The change of sleep, emotion, skin, and other related indicators of 90 participants after taking Tea Theanine Casein Hydrolysate Pressed Candy, whose active ingredients include tea theanine, casein hydrolysate, and saffron extract, was evaluated through a 28 days product placement test (sub study 1), and the emotional change of 70 participants after taking Tea Theanine Casein Hydrolysate Pressed Candy was evaluated through an EEG test (sub study 2).

Participants who meet the inclusion criteria were randomly assigned to use the experimental product or the placebo control. In sub study 1, 90 participants completed a 7-day baseline period, a 28-day testing period (T1d, T7d, and T28d). In sub study 2, 71 participants completed a single on-site test.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mild to Moderate Sleep Disorder Pressure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tea Theanine Casein Hydrolysate Pressed Candy

Take 4 Tea Theanine Casein Hydrolysate Pressed Candies once a day.

Group Type EXPERIMENTAL

Tea Theanine Casein Hydrolysate Pressed Candy

Intervention Type DIETARY_SUPPLEMENT

Take 4 candies once a day. It is recommended to consume it one hour before bedtime.

Pressed Candy

Take 4 Pressed Candies once a day.

Group Type PLACEBO_COMPARATOR

Pressed Candy

Intervention Type DIETARY_SUPPLEMENT

Take 4 candies once a day.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tea Theanine Casein Hydrolysate Pressed Candy

Take 4 candies once a day. It is recommended to consume it one hour before bedtime.

Intervention Type DIETARY_SUPPLEMENT

Pressed Candy

Take 4 candies once a day.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Chinese participants aged 20-55,
2. Mild to moderate sleep disorders (Pittsburgh Sleep Quality Index 5-21),
3. At least 2/3 of the population is under pressure (PSS-10 ≥ 14),
4. No plans to leave Shanghai in the past three months,
5. Have basic Chinese reading comprehension and expression abilities and can independently complete the questionnaire survey,
6. Voluntarily participate in the test and sign an informed consent form,
7. Willing to comply with all evaluation requirements, use the product according to the research protocol, and complete testing and follow-up. During the trial period, do not change the original dietary or skincare habits or use other similar foods, health products, or drugs.


1. Chinese participants aged 23-55,
2. Right-handedness (not acquired through training),
3. Pressure group (PSS-10 ≥ 14),
4. No plans to leave Shanghai in the past three months,
5. Have basic Chinese reading comprehension and expression abilities, and can independently complete the questionnaire survey,
6. Voluntarily participate in the test and sign an informed consent form,
7. Willing to comply with all evaluation requirements, use the product according to the research protocol, and complete testing.

Exclusion Criteria

1. Have used any food, health products, or medication with sleep aid and emotional relief effects within one month before the test,
2. History of tea allergy,
3. History of dairy product allergies,
4. Due to occupational reasons requiring night work or regular changes in working hours,
5. Regularly staying up late within one month before the test (not due to objective reasons or negative emotions, the frequency of staying up late is greater than once per week, such as playing games, watching TV shows, etc.),
6. Intending to become pregnant, or currently pregnant or breastfeeding,
7. Currently treating diseases other than sleep disorders,
8. Using facial and eye skincare products with whitening and spot-removing effects,
9. Has a history of alcohol abuse,
10. There were unhealed skin lesions on the face currently,
11. Have undergone surgical procedures, plastic surgery, or organ transplantation in the past year,
12. Any other health problems or chronic illnesses other than sleep and emotions,
13. Other iatrogenic reasons considered by the expert or professional may influence the evaluation outcome.

Sub study 2:


1. Have used any food, health products, or medication with sleep aid and emotional relief effects within one month before the test,
2. History of tea allergy,
3. History of dairy product allergies,
4. Unable to effectively induce negative emotions during on-site testing (POMS stress scale and panic scale scores after emotional induction are not higher than baseline),
5. Before testing, any obvious physiological discomfort, including but not limited to fever, hunger, dysmenorrhea, cough, lack of sleep, etc.,
6. Frequent insomnia and irregular sleep patterns within a month,
7. Anemia,
8. Abnormal blood sugar and blood pressure,
9. Neurological disorders,
10. Self-reported neurological or emotional disorders such as depression, anxiety, bipolar disorder, and obsessive-compulsive disorder diagnosed by clinical psychiatrists,
11. Alcohol, cigarette addiction, or drug dependence,
12. During drug treatment, ①The individual has systematically taken hypnotic drugs (barbiturates, etc.) or other central nervous system drugs within one year. ②The individual has systematically used anti-anxiety drugs (Benzodiazepines such as diazepam, chlorpromazine, and clonazepam), antiepileptic drugs (such as phenobarbital or clonazepam), antipsychotic, antidepressant, and anti-dementia drugs within one year.
13. Intending to become pregnant, or currently pregnant or breastfeeding,
14. Other iatrogenic reasons considered by the expert or professional may influence the outcome of the evaluation.
Minimum Eligible Age

20 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nu Skin Enterprises

INDUSTRY

Sponsor Role collaborator

ChinaNorm

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shanghai China-norm Quality Technical Service Co., Ltd.

Shanghai, Shanghai Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

W24002001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

30-Day MoonBrew Sleep & Stress Study
NCT06634914 NOT_YET_RECRUITING NA